HEADLIGHT : Understanding WHO’s Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. APCOM. (2014)

immage

The Guidelines aim to support countries provide more effective and comprehensive HIV services for the key populations, including men who have sex with men (MSM) and transgender people and include discussion of specific issues relating to adolescent key populations. Although, there is still a lack of evidence to support recommendation of PrEP to transgender women. In this brief we highlight the recommendations made in the Guidelines that are most relevant to MSM and transgender people. 

 


Keywords: HIV, key populations, MSM, transgender, adolescents, PrEP, ART, VMMC, HTC, TB

Download Publication

HIV and STI Prevalence, Vulnerability and Sexual Risk among Hijras and Other Male-to-Female Transgender People in India: A Research Synthesis and Meta-analysis. Chakrapani V. (2014)

immage

In the current fourth phase of National AIDS Control Programme (NACP-IV), Department of AIDS Control is planning to scale up HIV prevention interventions among hijras/TG people. The aim of this research synthesis was to summarise the current information on the prevalence of HIV and sexually transmitted infections (STIs), and the extent and contexts behind sexual risk behaviours among MtF transgender populations. This synthesis is expected to inform current and future actions to address the HIV/STI-related health needs of MtF transgender populations, and contribute to fine-tuning HIV programme and research agenda.

Download Publication

HIV/AIDS Issues for Transgender People in Japan. Taiga L. (2014)

immage

By Lily Taiga (Kansai University / MASH OSAKA / TGWAP)

 

Presentation presented at WPATH International global perspectives meeting
Dates : 14 Feb 2014 - 18 Feb 2014
Place :  Anantara Riverside, Bangkok, Thailand

Download Slide

Meeting Report: Funding the trans HIV Response Meeting of Trans Activists, Donors, and other Key Stakeholders. amfAR, Global Action for Trans Equality, International Reference Group on Trans and Gender Variant Communities and HIV/AIDS, et al. (2014)

immage

Objectives for the meeting included:

• Highlighting existing data on the state of the trans* movement and the level of current investments by GFATM, PEPFAR, and other funders for HIV-focused trans* service delivery, advocacy, and research efforts at the local and national levels.
• Identifying opportunities and barriers for trans* organizations and communities participation in the country dialogue process of GFATM’s and PEPFAR’s country operational plans Strategizing about short-term and medium-term concrete actions that trans* activists, GFATM and PEPFAR representatives, and other stakeholders can take to increase trans* engagement in GFATM and PEPFAR funding processes
• Establishing mechanisms for ongoing dialogue between trans* activists and representatives from GFATM and PEPFAR.


Keywords: key Populations, LGBT, transgender, Thailand 

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Afghanistan. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Bangladesh. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Bhutan. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Cambodia. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Fiji. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in India. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_May-AIDSreg2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Oct
11
Nov
14
Nov
20